Renpho
Renpho

Economy

NIA announces funding for longevity clinical trials

New funding opportunity for longevity clinical trials from National Institute on Aging emphasises preventing aging and age-related disease. The NIA,...

The trillion dollar upside to longevity

New economic model estimates that targeting aging has larger economic gains than eradicating individual diseases: time for a policy pivot? Although life expectancy has increased...

Open Life secures funding for longer, healthier lives

Open Life data project secures funding to help UK develop pandemic resilience and promote healthy life extension. The All Party-Parliamentary Group (APPG) for Longevity has...

Latest news

International Day of Women and Girls in Science

As we celebrate International Day of Women and Girls in Science, here are just a few of the names to be found in our...

Open Life secures funding for longer, healthier lives

Open Life data project secures funding to help UK develop pandemic resilience and promote healthy life extension. The All Party-Parliamentary Group (APPG) for Longevity has...

British biotech success is longevity confidence boost

UK business confidence is at six-year high as biotech innovation and vaccine success dispel lockdown gloom. Data from IHS Markit demonstrates that British business confidence...

Longevity leaders call for trials of rapamycin to treat COVID-19

Lancet commentary calls for immediate large-scale clinical trials of rapamycin and rapalogs, with geroprotective consequences. In March last year, as the global coronavirus pandemic took...

We are what we eat: Jim Mellon exclusive

Longevity, biotech, investment, sustainability and ethics: Jim Mellon's new book, MOO'S LAW, addresses the opportunities and challenges of our need for protein. Getting time with...

A year in longevity: investment perspectives

New funds, switching focus to longevity, Silicon Valley blue-bloods and preparing for IPO. Over the past year, we’ve had the pleasure of speaking with some...

A year in Longevity: progress perspectives

2020's journey to extending healthy human longevity. The journey to Longevity has many stages, whether it's a clinical pipeline, gaining regulatory approval for a drug,...

A year in Longevity: different perspectives

Looking for anti-aging solutions in some unusual places. 2020 has seen Longevity.Technology covering a variety of news in the Longevity sector, from discoveries in the...

A year in Longevity: founders’ perspectives

Speaking to the innovators behind some of Longevity’s most exciting companies. Continuing our look back at some of the highlights of 2020, we thought we’d...
Renpho
Longevity.Technology welcome banner

A year in Longevity: science perspectives

Longevity leaders on the key issues facing our sector. Over the past year, we’ve had the pleasure of speaking to some of the Longevity sector’s...

Let’s initiate trials of potential geroprotective therapies

Dr Lynne Cox explains the importance of geroprotectors – especially during COVID-19. This month The Lancet launches its own journal on Longevity, publishing clinically-focused Longevity and...

Tina Woods: Prevention is vital for Longevity

Longevity International’s Tina Woods tells us how the Longevity industry is releasing us from being trapped in the cycle of ill health and chronic...

Longevity FinTech: a new contract between finance and aging

Academic proposes that FinTech and InsurTech can be a key enabler of new financial approaches for older people. Ira Sobel is the founder of FinTech...

Most popular

The trillion dollar upside to longevity

New economic model estimates that targeting aging has larger economic gains than eradicating individual diseases: time for a policy pivot? Although life expectancy has increased...

Mouse studies and safety to accelerate longevity drugs

Professor Mikhail Blagosklonny takes a look at therapeutic research done within the longevity field and concludes that there must be a re-focusing on lifespan...

We are what we eat: Jim Mellon exclusive

Longevity, biotech, investment, sustainability and ethics: Jim Mellon's new book, MOO'S LAW, addresses the opportunities and challenges of our need for protein. Getting time with...

International Day of Women and Girls in Science

As we celebrate International Day of Women and Girls in Science, here are just a few of the names to be found in our...
Apollo Neuro

You might also like

The Sheekey Science Show: NAD+ rejuvenation strategies

NAD+ metabolism in aging & three strategies to rejuvenate. Welcome to The Sheekey Science Show! Longevity.Technology is delighted to partner with YouTube sensation Eleanor Sheekey (interviewed...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

BioAge kicks off Phase 2 longevity clinical trial

Company reveals primary indicator for BGE-117 clinical trial is unexplained anaemia of aging. Hot on the heels of its monster $90 million Series C funding...

Review: Sensate

You’ve heard of the Rock, well this is the pebble! Our intrepid reviewer spent 30 days using the Sensate 2 device and here is...
TruNigen pf